Medicago, GSK’s plant-based Covid-19 vaccine approved in Canada
Covifenz leverages CoVLP technology, comprises recombinant spike (S) glycoprotein, and is co-administered with GSK’s pandemic adjuvant
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 Feb 22
Covifenz leverages CoVLP technology, comprises recombinant spike (S) glycoprotein, and is co-administered with GSK’s pandemic adjuvant
24 Feb 22
Sanofi and GSK’s vaccine is said to have induced superior immune responses and a favourable safety profile, both…
24 Feb 22
Thermo Fisher will provide dedicated capacity to scale-up the production of Moderna’s Covid-19 vaccine, and other potential mRNA…
23 Feb 22
We focus on how distributed ledger technology (DLT) has been implemented by the NHS to monitor storage and…
23 Feb 22
The company has a commercial footprint in 56 countries worldwide and is planning to expand its presence in…
We focus on what sponsors should look for when outsourcing to a central lab in China and other…
22 Feb 22
Corbevax is a receptor-binding domain (RBD) protein sub-unit Covid-19 vaccine and is India’s first indigenously developed Covid-19 vaccine
21 Feb 22
In the interim analysis, Dupixent showed positive results in reducing itch and hives (primary endpoints) but did not…
18 Feb 22
The US agency has accepted the company’s supplemental Biologics License Application (sBLA) for the drug to expand its…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
17 Feb 22
The announcement builds on Moderna’s recent plans to expand in the Asia-Pacific region and will establish a local…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates